Status:
RECRUITING
Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy
Lead Sponsor:
Chinese PLA General Hospital
Collaborating Sponsors:
Beijing Municipal Science & Technology Commission
China-Japan Friendship Hospital
Conditions:
Diabetic Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
With the rapid increase of diabetic nephropathy worldwide, type 2 diabetes mellitus(DM) is the leading cause of end-stage renal disease(ESRD). Pathological types of diabetic kidney disease(DKD) could ...
Eligibility Criteria
Inclusion
- Age≥18, male or female
- Clinical diagnosed as type 2 diabetes mellitus
- The presence of renal impairment including: microalbuminuria or overt proteinuria or renal insufficiency
- The renal biopsy was performed with complete renal pathological diagnosis
- Obtaining the signed informed consent from patients
Exclusion
- The history of the disease was not complete
- Clinical diagnosed as other secondary renal diseases
- Patients with hereditary kidney disease
- Autoimmune diseases
- Patients with malignant tumor were expected to survive less than 6 months
- Pregnancy and lactation
Key Trial Info
Start Date :
November 30 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03865914
Start Date
November 30 2017
End Date
December 31 2030
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853